— Know what they know.
Not Investment Advice

WVE NASDAQ

Wave Life Sciences Ltd.
1W: -7.0% 1M: -13.0% 3M: -52.4% YTD: -59.8% 1Y: -1.8% 3Y: +73.0% 5Y: +3.4%
$6.38
-0.04 (-0.62%)
 
Weekly Expected Move ±7.3%
$6 $6 $7 $7 $8
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 31 · $1.2B mcap · 158M float · 3.09% daily turnover · Short 49% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
39.1 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: 267.8%
Cost Advantage
45
Intangibles
55
Switching Cost
18
Network Effect
52
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. WVE has No discernible competitive edge (39.1/100). The business operates without significant structural advantages. The primary source of advantage is Intangible Assets. ROIC of 267.8% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$13
Low
$14
Avg Target
$15
High
Based on 3 analysts since Apr 28, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 23Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$15.17
Analysts6
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-20 Wells Fargo $13 $14 +1 +128.0% $6.14
2026-05-19 H.C. Wainwright $18 $13 -5 +103.1% $6.40
2026-04-29 Truist Financial $50 $15 -35 +99.5% $7.52
2026-04-14 H.C. Wainwright Andrew Fein $30 $18 -12 +147.9% $7.26
2026-03-27 Wells Fargo $27 $13 -14 +104.1% $6.37
2026-03-26 Jefferies Initiated $18 +190.3% $6.20
2026-02-12 Wells Fargo $29 $27 -2 +103.5% $13.27
2026-02-03 Canaccord Genuity $40 $43 +3 +220.2% $13.43
2026-02-02 Raymond James Michael Freeman $21 $26 +5 +93.6% $13.43
2025-12-19 H.C. Wainwright Andrew Fein Initiated $30 +81.1% $16.57
2025-12-16 UBS $30 $32 +2 +98.6% $16.11
2025-12-16 Oppenheimer Cheng Li Initiated $32 +88.5% $16.98
2025-12-15 Truist Financial $36 $50 +14 +201.0% $16.61
2025-12-12 Wedbush Yun Zhong Initiated $33 +97.1% $16.74
2025-12-09 Cantor Fitzgerald Steve Seedhouse $12 $34 +22 +76.4% $19.27
2025-12-09 Wells Fargo $18 $29 +11 +56.6% $18.52
2025-12-09 UBS Initiated $30 +62.0% $18.52
2025-12-08 RBC Capital $15 $27 +12 +45.8% $18.52
2025-12-08 Raymond James $22 $21 -1 +13.4% $18.52
2025-12-08 Canaccord Genuity Initiated $40 +116.0% $18.52
2025-12-08 Morgan Stanley Initiated $28 +51.2% $18.52
2025-10-27 Cantor Fitzgerald Steve Seedhouse Initiated $12 +68.3% $7.13
2025-09-04 Wells Fargo Tiago Fauth $22 $18 -4 +125.0% $8.00
2025-09-03 Leerink Partners $22 $26 +4 +225.0% $8.00
2024-11-12 Truist Financial Joon Leen $17 $36 +19 +166.9% $13.49
2024-10-21 RBC Capital Luca Issi Initiated $15 +1.4% $14.80
2024-10-17 Wells Fargo Tiago Fauth $11 $22 +11 +47.7% $14.90
2024-10-16 Raymond James Strong Buy Initiated $22 +48.5% $14.81
2024-10-16 Leerink Partners Joseph Schwartz Initiated $22 +46.2% $15.05
2024-10-03 B.Riley Financial Madison El-Saadi $11 $19 +8 +119.7% $8.65
2024-09-25 Mizuho Securities Salim Syed Initiated $19 +132.0% $8.19
2024-09-25 B.Riley Financial Madison El-Saadi Initiated $11 +34.3% $8.19
2024-06-25 Truist Financial Joon Leen Initiated $17 +256.4% $4.77
2024-05-15 Wells Fargo Tiago Fauth Initiated $11 +88.4% $5.84

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
2
ROE
1
ROA
1
D/E
3
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. WVE receives an overall rating of C. Areas of concern: DCF (2/5), ROE (1/5), ROA (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-18 C- C
2026-05-14 C C-
2026-04-28 D+ C
2026-04-21 C- D+
2026-04-13 D+ C-
2026-04-01 C- D+
2026-01-03 D+ C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

28 Grade D
Profitability
20
Balance Sheet
86
Earnings Quality
80
Growth
12
Value
38
Momentum
20
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. WVE scores highest in Safety (100/100) and lowest in Growth (12/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
4.95
Safe Zone
Piotroski F-Score
4/9
Beneish M-Score
-0.42
Possible Manipulator
Ohlson O-Score
-5.60
Bankruptcy prob: 0.4%
Low Risk
Credit Rating
A+
Score: 75.6/100
Trend: Improving
Earnings Quality
OCF/NI: 0.99x
Accruals: -0.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. WVE scores 4.95, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. WVE scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. WVE's score of -0.42 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. WVE's implied 0.4% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. WVE receives an estimated rating of A+ (score: 75.6/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-6.96x
PEG
0.12x
P/S
17.10x
P/B
2.50x
P/FCF
-7.92x
P/OCF
EV/EBITDA
-4.76x
EV/Revenue
12.07x
EV/EBIT
-4.54x
EV/FCF
-4.73x
Earnings Yield
-12.65%
FCF Yield
-12.63%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. WVE currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.961
EBT / EBIT
×
EBIT Margin
-2.661
EBIT / Rev
×
Asset Turnover
0.145
Rev / Assets
×
Equity Multiplier
1.347
Assets / Equity
=
ROE
-49.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. WVE's ROE of -49.9% is driven by Asset Turnover (0.145), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$6.38
Median 1Y
$2.87
5th Pctile
$0.52
95th Pctile
$15.89
Ann. Volatility
105.0%
Analyst Target
$15.17
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Paul B. Bolno,
M.D., MBA President and Chief Executive Officer
$655,500 $— $4,272,299
Kyle Moran, CFA
Chief Financial Officer
$497,200 $— $1,917,381
Chandra Vargeese, Ph.D.
Chief Technology Officer, Head of Platform Discovery Sciences
$487,540 $— $1,888,563
Christopher Francis, Ph.D.
Senior Vice President, Corporate Development and Head of Emerging Areas
$438,300 $— $1,566,422

CEO Pay Ratio

18:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $4,272,299
Avg Employee Cost (SGA/emp): $237,637
Employees: 317

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
317
+10.4% YoY
Revenue / Employee
$134,785
Rev: $42,727,000
Profit / Employee
$-644,726
NI: $-204,378,000
SGA / Employee
$237,637
Avg labor cost proxy
R&D / Employee
$576,590
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -1.8% -1.4% -2.0% -1.9% -2.0% -2.5% 25.7% 24.0% 20.8% 13.5% 21.1% 22.6% 26.9% 52.2% -77.9% -90.2% -1.0% -97.9% -55.6% -49.9% -49.90%
ROA -50.8% -41.3% -50.3% -48.4% -49.4% -62.9% -91.6% -85.7% -74.3% -48.1% -27.3% -29.3% -34.9% -67.7% -30.9% -35.8% -41.4% -38.9% -41.3% -37.1% -37.06%
ROIC 1.8% 1.5% 1.1% 1.1% 1.1% 1.4% 1.3% 1.3% 1.1% 76.5% 41.8% 44.3% 51.4% 93.4% 1.3% 1.5% 1.7% 1.6% 2.9% 2.7% 2.68%
ROCE -93.6% -76.6% -88.9% -85.2% -86.8% -1.1% -2.2% -2.1% -1.8% -1.2% -76.8% -81.5% -94.6% -1.7% -45.8% -52.1% -59.5% -55.3% -38.6% -35.2% -35.16%
Gross Margin -10.4% 14.7% -13.6% -14.7% -78.3% -95.8% -24.1% -1.4% -50.7% 35.7% 92.5% 1.0% 1.0% 1.0% 1.0% 76.4% 74.8% 1.0% 86.9% 1.0% 1.00%
Operating Margin -14.3% -20.9% -20.5% -21.8% -112.4% -136.5% -35.2% -2.3% -1.1% 9.0% -64.3% -2.7% -1.8% 8.3% 27.4% -5.4% -6.1% -7.4% -3.3% -81.8% -81.83%
Net Margin -14.0% -17.1% -19.7% -21.6% -110.1% -136.9% -35.3% -2.1% -95.5% 14.7% -55.9% -2.5% -1.7% 8.0% 34.9% -5.1% -5.8% -7.1% -3.1% -68.2% -68.21%
EBITDA Margin -13.7% -15.8% -19.5% -20.8% -107.9% -130.7% -33.9% -2.2% -1.0% 11.5% -56.8% -2.6% -1.7% 8.0% 30.0% -5.2% -5.8% -6.8% -3.0% -75.8% -75.81%
FCF Margin -6.8% -2.4% -2.2% -2.0% -2.6% -24.6% -35.4% -27.2% -32.9% -24.1% -18.1% -1.2% -1.2% -2.6% -1.4% -1.7% -2.1% -1.8% -4.4% -2.6% -2.55%
OCF Margin -6.7% -2.3% -2.2% -2.0% -2.6% -24.3% -35.0% -16.1% -29.6% -23.0% -17.1% -1.2% -1.2% -2.6% -1.4% -1.7% -2.1% -1.8% -4.3% -2.5% -2.54%
ROE 3Y Avg snapshot only -81.37%
ROA 3Y Avg snapshot only -27.69%
ROIC Economic snapshot only -28.67%
Cash ROA snapshot only -28.56%
NOPAT Margin snapshot only -2.17%
Pretax Margin snapshot only -2.56%
R&D / Revenue snapshot only 2.64%
SGA / Revenue snapshot only 1.10%
SBC / Revenue snapshot only 30.27%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -2.33 -2.14 -1.47 -1.03 -1.80 -2.22 -4.07 -2.92 -2.93 -7.24 -9.63 -12.93 -8.80 -7.63 -21.97 -11.69 -8.21 -10.07 -14.98 -7.90 -6.956
P/S Ratio 21.25 5.11 4.38 2.83 5.36 81.19 180.31 29.80 10.50 7.20 4.89 7.06 5.85 20.28 19.68 12.51 11.35 11.24 71.68 20.21 17.097
P/B Ratio 3.67 2.74 5.53 3.72 6.65 10.43 -14.59 -9.80 -8.51 -13.64 13.97 20.13 16.31 27.43 10.17 6.27 5.09 5.86 5.82 2.76 2.496
P/FCF -3.13 -2.17 -2.01 -1.42 -2.06 -3.31 -5.09 -109.71 -31.88 -29.87 -26.95 -5.72 -4.99 -7.66 -14.02 -7.24 -5.33 -6.20 -16.42 -7.92 -7.916
P/OCF
EV/EBITDA -1.27 -0.83 -0.50 -0.00 -0.82 -1.47 -3.89 -2.63 -2.55 -6.45 -6.23 -9.63 -6.29 -6.41 -18.23 -8.85 -5.85 -7.63 -12.35 -4.76 -4.761
EV/Revenue 11.34 1.92 1.44 0.01 2.37 52.30 166.37 26.37 9.11 6.60 3.40 5.57 4.33 17.14 17.12 9.88 8.40 8.71 58.00 12.07 12.074
EV/EBIT -1.20 -0.77 -0.46 -0.00 -0.77 -1.41 -3.73 -2.52 -2.44 -6.07 -5.67 -8.72 -5.71 -6.04 -16.80 -8.24 -5.50 -7.13 -11.82 -4.54 -4.537
EV/FCF -1.67 -0.81 -0.66 -0.00 -0.91 -2.13 -4.70 -97.08 -27.65 -27.40 -18.76 -4.51 -3.69 -6.48 -12.20 -5.72 -3.94 -4.80 -13.28 -4.73 -4.729
Earnings Yield -43.0% -46.8% -68.1% -97.2% -55.6% -45.1% -24.6% -34.3% -34.2% -13.8% -10.4% -7.7% -11.4% -13.1% -4.6% -8.6% -12.2% -9.9% -6.7% -12.7% -12.65%
FCF Yield -32.0% -46.1% -49.9% -70.4% -48.5% -30.3% -19.6% -0.9% -3.1% -3.3% -3.7% -17.5% -20.1% -13.0% -7.1% -13.8% -18.8% -16.1% -6.1% -12.6% -12.63%
PEG Ratio snapshot only 0.122
Price/Tangible Book snapshot only 2.758
EV/Gross Profit snapshot only 12.874
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.90 1.90 2.53 2.53 2.53 2.53 1.38 1.38 1.38 1.38 1.26 1.26 1.26 1.26 2.89 2.89 2.89 2.89 6.47 6.47 6.467
Quick Ratio 1.90 1.90 2.53 2.53 2.53 2.53 1.38 1.38 1.38 1.38 1.26 1.26 1.26 1.26 2.89 2.89 2.89 2.89 6.47 6.47 6.467
Debt/Equity 0.32 0.32 0.92 0.92 0.92 0.92 -0.83 -0.83 -0.83 -0.83 0.81 0.81 0.81 0.81 0.12 0.12 0.12 0.12 0.03 0.03 0.034
Net Debt/Equity -1.71 -1.71 -3.71 -3.71 -3.71 -3.71 -4.25 -4.25 -4.25 -4.25 -1.32 -1.32 -1.32 -1.32 -1.11 -1.11 -1.110
Debt/Assets 0.10 0.10 0.14 0.14 0.14 0.14 0.26 0.26 0.26 0.26 0.12 0.12 0.12 0.12 0.07 0.07 0.07 0.07 0.03 0.03 0.028
Debt/EBITDA -0.21 -0.26 -0.25 -0.26 -0.26 -0.20 -0.24 -0.25 -0.29 -0.43 -0.52 -0.49 -0.42 -0.22 -0.25 -0.22 -0.19 -0.20 -0.09 -0.10 -0.098
Net Debt/EBITDA 1.11 1.37 1.01 1.05 1.03 0.81 0.33 0.34 0.39 0.58 2.72 2.58 2.21 1.17 2.72 2.36 2.05 2.22 2.91 3.21 3.209
Interest Coverage -8707.47 -1478.73 -1549.71 -1475.34 -1297.33
Equity Multiplier 3.08 3.08 6.37 6.37 6.37 6.37 -3.25 -3.25 -3.25 -3.25 6.94 6.94 6.94 6.94 1.68 1.68 1.68 1.68 1.21 1.21 1.213
Cash Ratio snapshot only 6.333
Cash to Debt snapshot only 33.889
FCF to Debt snapshot only -10.320
Defensive Interval snapshot only 833.5 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.06 0.17 0.17 0.18 0.17 0.02 0.02 0.08 0.21 0.48 0.54 0.54 0.52 0.25 0.35 0.33 0.30 0.35 0.09 0.14 0.145
Inventory Turnover
Receivables Turnover 0.63 1.95 2.73 2.85 2.69 0.28 10.75 10.71 10.48 5.08 9.62 9.32 8.35 9.71 31.67 53.22 53.223
Payables Turnover 7.87 8.11 8.40 11.00 10.82 10.49 9.58 9.87 10.16 10.50 6.60 4.51 2.27 0.15 0.00 0.15 0.30 0.30 0.41 0.28 0.279
DSO 583 188 134 128 136 1311 0 0 0 0 34 34 35 72 38 39 44 38 12 7 6.9 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 46 45 43 33 34 35 38 37 36 35 55 81 161 2489 2454 1218 1218 881 1308 1308.4 days
Cash Conversion Cycle 536 143 90 95 102 1277 -38 -37 -36 -35 -21 -47 -126 -2417 -2415 -1174 -1180 -869 -1302 -1301.6 days
Fixed Asset Turnover snapshot only 3.615
Cash Velocity snapshot only 0.119
Capital Intensity snapshot only 8.893
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 25.1% 2.7% 1.0% 1.7% 1.6% -91.4% -91.1% -65.3% -9.3% 19.5% 30.1% 6.6% 2.0% -37.3% -4.4% -7.1% -15.0% 1.0% -60.5% -31.6% -31.58%
Net Income 26.8% 34.7% 18.5% 18.8% 16.1% -31.5% -32.4% -28.8% -9.2% 44.4% 64.5% 59.3% 44.0% -67.7% -68.7% -82.2% -76.7% 14.4% -1.1% -63.4% -63.44%
EPS 48.4% 50.6% 30.5% 34.1% 36.9% 29.0% 19.5% 23.6% 31.1% 51.2% 69.5% 67.8% 54.4% -35.4% -7.3% -44.9% -39.6% 32.4% -1.0% -32.7% -32.70%
FCF 38.1% 22.6% 23.7% 36.9% 1.6% 10.4% -44.2% 95.3% 88.5% 79.9% 84.1% -33.6% -9.8% -5.9% -6.4% -30.0% -54.4% -39.7% -22.8% -1.1% -1.11%
EBITDA 28.4% 35.6% 18.1% 17.3% 16.2% -31.4% -31.2% -30.0% -11.5% 41.1% 60.4% 56.1% 41.7% -63.9% -64.4% -79.3% -77.5% 13.0% -97.3% -55.5% -55.51%
Op. Income 27.2% 34.0% 17.2% 17.2% 16.2% -28.1% -28.1% -27.4% -9.9% 40.2% 58.2% 53.4% 38.6% -63.7% -62.4% -74.2% -71.5% 10.6% -95.1% -56.6% -56.56%
OCF Growth snapshot only -0.95%
Asset Growth snapshot only 81.29%
Equity Growth snapshot only 1.51%
Debt Growth snapshot only -30.07%
Shares Change snapshot only 23.16%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 21.9% 57.4% 41.6% 38.7% 29.0% -37.6% -38.9% -4.7% 42.9% 87.2% 78.0% 92.1% 91.8% 3.3% 38.3% 34.9% 32.6% 2.0% 1.3% 69.2% 69.18%
Revenue 5Y 94.1% 1.2% 94.1% 81.6% 75.5% 9.1% -0.3% 27.2% 33.4% 47.0% 51.0% 47.8% 42.6% 25.5% 46.6% 43.7% 49.6% 53.0% 16.3% 35.2% 35.16%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 15.4% 15.4% -11.2% -11.2% -11.2% -11.2% -19.8% -19.8% -19.8% -19.8% -0.5% -0.5% -0.5% -0.5% 19.4% 19.4% 19.4% 19.4% 63.4% 63.4% 63.39%
Assets 5Y 11.0% 11.0% 4.7% 4.7% 4.7% 4.7% -4.2% -4.2% -4.2% -4.2% -1.5% -1.5% -1.5% -1.5% 4.4% 4.4% 4.4% 4.4% 18.0% 18.0% 17.99%
Equity 3Y -13.4% -13.4% -23.8% -23.8% -23.8% -23.8% -24.1% -24.1% -24.1% -24.1% 86.1% 86.1% 86.1% 86.1%
Book Value 3Y -27.7% -27.9% -36.8% -38.0% -38.9% -45.5% -42.1% -45.0% -44.7% -44.9% 28.9% 33.9% 37.7% 53.4%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.68 0.68 0.85 0.74 0.68 0.12 0.10 0.31 0.76 0.36 0.37 0.45 0.60 0.30 0.56 0.62 0.77 0.65 0.23 0.48 0.477
Earnings Stability 0.72 0.47 0.35 0.21 0.14 0.15 0.09 0.00 0.09 0.35 0.44 0.56 0.73 0.36 0.63 0.57 0.51 0.20 0.01 0.01 0.013
Margin Stability 0.28 0.06 0.06 0.14 0.12 0.24 0.12 0.18 0.24 0.00 0.00 0.16 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.50 0.50 1.00 0.50 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.000
Earn. Growth Consistency 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.89 0.86 0.93 0.92 0.94 0.87 0.87 0.88 0.96 0.82 0.50 0.50 0.82 0.50 0.50 0.50 0.50 0.94 0.50 0.50 0.500
Earnings Smoothness
ROE Trend 0.89 1.15 -1.58 -1.44 -1.54 -2.82 0.57 0.70 0.697
Gross Margin Trend 5.02 8.67 6.59 5.26 6.69 -19.77 -27.41 -3.87 0.92 12.71 16.09 4.79 2.79 13.94 16.31 4.30 1.79 0.72 0.28 0.25 0.246
FCF Margin Trend 4.18 8.14 6.75 7.16 7.66 -17.71 -31.38 4.97 4.37 13.22 18.61 -0.10 0.29 9.76 16.38 -0.97 -1.38 -0.37 -3.57 -1.07 -1.072
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.74 0.98 0.73 0.72 0.87 0.66 0.79 0.02 0.08 0.23 0.34 2.24 1.75 0.99 1.56 1.61 1.53 1.62 0.91 0.99 0.993
FCF/OCF 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.69 1.11 1.05 1.06 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.01 1.005
FCF/Net Income snapshot only 0.999
CapEx/Revenue 6.8% 2.3% 1.4% 1.5% 2.0% 28.1% 37.3% 11.1% 3.3% 1.1% 1.0% 0.9% 0.9% 2.3% 0.9% 0.7% 1.0% 0.7% 1.7% 1.4% 1.37%
CapEx/Depreciation snapshot only 0.109
Accruals Ratio -0.13 -0.01 -0.14 -0.14 -0.07 -0.21 -0.19 -0.84 -0.68 -0.37 -0.18 0.36 0.26 -0.01 0.17 0.22 0.22 0.24 -0.04 -0.00 -0.002
Sloan Accruals snapshot only 0.608
Cash Flow Adequacy snapshot only -185.699
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -46.5% -8.5% -30.6% -39.6% -43.7% -25.4% -8.0% -19.4% -9.4% -6.1% -23.7% -13.9% -16.9% -27.3% -11.1% -17.0% -21.9% -6.2% -15.8% -33.5% -33.52%
Total Shareholder Return -46.5% -8.5% -30.6% -39.6% -43.7% -25.4% -8.0% -19.4% -9.4% -6.1% -23.7% -13.9% -16.9% -27.3% -11.1% -17.0% -21.9% -6.2% -15.8% -33.5% -33.52%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.02 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 0.96 0.95 0.96 0.97 0.97 0.98 0.99 0.97 0.96 0.90 0.84 0.85 0.87 0.94 0.88 0.89 0.90 0.91 0.98 0.96 0.961
EBIT Margin -9.45 -2.49 -3.10 -2.85 -3.08 -37.19 -44.59 -10.45 -3.73 -1.09 -0.60 -0.64 -0.76 -2.84 -1.02 -1.20 -1.53 -1.22 -4.91 -2.66 -2.661
Asset Turnover 0.06 0.17 0.17 0.18 0.17 0.02 0.02 0.08 0.21 0.48 0.54 0.54 0.52 0.25 0.35 0.33 0.30 0.35 0.09 0.14 0.145
Equity Multiplier 3.47 3.47 3.95 3.95 3.95 3.95 -28.06 -28.06 -28.06 -28.06 -77.15 -77.15 -77.15 -77.15 2.52 2.52 2.52 2.52 1.35 1.35 1.347
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-2.86 $-2.29 $-2.14 $-1.94 $-1.81 $-1.63 $-1.72 $-1.48 $-1.24 $-0.79 $-0.52 $-0.48 $-0.57 $-1.08 $-0.56 $-0.69 $-0.79 $-0.73 $-1.13 $-0.92 $-0.92
Book Value/Share $1.81 $1.79 $0.57 $0.54 $0.49 $0.35 $-0.48 $-0.44 $-0.43 $-0.42 $0.36 $0.31 $0.31 $0.30 $1.22 $1.29 $1.28 $1.25 $2.92 $2.63 $2.56
Tangible Book/Share $1.81 $1.79 $0.57 $0.54 $0.49 $0.35 $-0.48 $-0.44 $-0.43 $-0.42 $0.36 $0.31 $0.31 $0.30 $1.22 $1.29 $1.28 $1.25 $2.92 $2.63 $2.63
Revenue/Share $0.31 $0.96 $0.72 $0.71 $0.61 $0.04 $0.04 $0.15 $0.35 $0.80 $1.03 $0.87 $0.85 $0.40 $0.63 $0.65 $0.57 $0.65 $0.24 $0.36 $0.36
FCF/Share $-2.13 $-2.26 $-1.57 $-1.41 $-1.58 $-1.09 $-1.37 $-0.04 $-0.11 $-0.19 $-0.19 $-1.08 $-1.00 $-1.07 $-0.88 $-1.12 $-1.22 $-1.18 $-1.04 $-0.92 $-0.92
OCF/Share $-2.11 $-2.24 $-1.56 $-1.40 $-1.56 $-1.08 $-1.36 $-0.02 $-0.10 $-0.18 $-0.18 $-1.07 $-0.99 $-1.06 $-0.88 $-1.11 $-1.21 $-1.18 $-1.03 $-0.91 $-0.91
Cash/Share $3.69 $3.64 $2.63 $2.49 $2.26 $1.60 $0.94 $0.87 $0.84 $0.83 $1.83 $1.55 $1.55 $1.51 $1.75 $1.86 $1.84 $1.80 $3.34 $3.01 $2.72
EBITDA/Share $-2.79 $-2.23 $-2.08 $-1.89 $-1.76 $-1.58 $-1.66 $-1.46 $-1.24 $-0.82 $-0.56 $-0.51 $-0.59 $-1.08 $-0.59 $-0.72 $-0.82 $-0.74 $-1.11 $-0.91 $-0.91
Debt/Share $0.59 $0.58 $0.52 $0.49 $0.45 $0.32 $0.40 $0.37 $0.36 $0.35 $0.29 $0.25 $0.25 $0.24 $0.15 $0.16 $0.15 $0.15 $0.10 $0.09 $0.09
Net Debt/Share $-3.11 $-3.06 $-2.11 $-1.99 $-1.81 $-1.28 $-0.54 $-0.50 $-0.48 $-0.48 $-1.53 $-1.30 $-1.30 $-1.27 $-1.61 $-1.70 $-1.69 $-1.65 $-3.24 $-2.92 $-2.92
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 4.950
Altman Z-Prime snapshot only 10.130
Piotroski F-Score 4 5 4 4 4 2 1 2 3 4 5 4 4 2 3 2 2 4 3 4 4
Beneish M-Score -3.06 -21.47 -6.26 -6.28 -25.49 -4.15 3.65 126.55 6.64 2.76 -2.52 -2.52 -0.94 -2.65 -3.00 -1.10 -0.42 -0.421
Ohlson O-Score snapshot only -5.600
ROIC (Greenblatt) snapshot only -35.41%
Net-Net WC snapshot only $2.51
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A+
Credit Score 26.01 37.30 37.92 39.26 39.92 28.09 20.00 20.00 20.00 20.00 36.19 36.00 35.95 36.10 75.91 49.71 43.90 49.15 76.15 75.61 75.608
Credit Grade snapshot only 5
Credit Trend snapshot only 25.899
Implied Spread (bps) snapshot only 125.000
Industry Credit Rank snapshot only 76
Sector Credit Rank snapshot only 70

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms